Teva Pharmaceutical Industries Limited (TEVA) : Company Profile and SWOT AnalysisWorld Market IntelligenceJuly 20, 2012 56 Pages - SKU: WLMI4854081 |
- 1 Business Analysis
- 1.1 Company Overview
- 1.2 Business Description
- 1.3 Major Products and Services
- 2 Analysis of Key Performance Indicators
- 2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
- 2.2 Key Financial Performance Indicators
- 2.2.1 Revenue and Operating Profit
- 2.2.2 Asset and Liabilities
- 2.2.3 Net Debt vs. Gearing Ratio
- 2.2.4 Operational Efficiency
- 2.2.5 Solvency
- 2.2.6 Valuation
- 2.3 Competitive Benchmarking
- 2.3.1 Market Capitalization
- 2.3.2 Efficiency
- 2.3.3 Valuation
- 2.3.4 Turnover – Inventory and Asset
- 2.3.5 Liquidity
- 3 Mergers & Acquisitions and Partnerships
- 3.1 M&A and Partnerships Strategy
- 4 SWOT Analysis
- 4.1 SWOT Analysis - Overview
- 4.2 Strengths
- 4.3 Weaknesses
- 4.4 Opportunities
- 4.5 Threats
- 5 Company Statement
- 6 History
- 7 Key Employees
- 8 Key Employee Biographies
- 9 Locations and Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations and Subsidiaries
- 10 Appendix
- 10.1 Methodology
- 10.2 Ratio Definitions
- 10.3 Disclaimer
- List of Tables
- Table 1: Major Products and Services
- Table 2: Key Ratios - Annual
- Table 3: Key Ratios - Interim
- Table 4: Key Capital Market Indicators
- Table 5: History
- Table 6: Key Employees
- Table 7: Key Employee Biographies
- Table 8: Subsidiaries
- Table 9: Locations
- List of Figures
- Figure 1: Revenue and Operating Profit
- Figure 2: Financial Position
- Figure 3: Net Debt vs. Gearing Ratio
- Figure 4: Operational Efficiency
- Figure 5: Solvency
- Figure 6: Valuation
- Figure 7: Market Capitalization
- Figure 8: Efficiency
- Figure 9: Valuation
- Figure 10: Turnover – Inventory and Asset
- Figure 11: Liquidity
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
- PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
- Notable News in the Life Sciences: 1Q13
- Immunomedics, Inc. – Product Pipeline Review – 2013
- Richter Gedeon Nyrt. – Product Pipeline Review – 2013
